Especially, Recent processes in molecular biology have confirmed that FGFR1 amplification is detected in approximately 20% of lung squamous cell carcinoma (SqCC) 19 and is associated with the mechanism of acquired resistance to EGFR-TKIs 26,27. The gene discussed is EGFR; the disease is squamous cell lung carcinoma.